BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29372612)

  • 21. Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin.
    Kaleağasıoğlu F; Olcay E; Olgaç V
    Knee Surg Sports Traumatol Arthrosc; 2017 Jun; 25(6):1884-1891. PubMed ID: 26275370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
    Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
    Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.
    Stoekenbroek RM; Boekholdt SM; Fayyad R; Laskey R; Tikkanen MJ; Pedersen TR; Hovingh GK;
    Heart; 2015 Mar; 101(5):356-62. PubMed ID: 25595417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of statins on blood pressure: Analysis on adverse events released by FDA.
    You T; Liu XG; Hou XD; Wang XK; Xie HH; Ding F; Yi K; Zhang P; Xie XD
    Clin Exp Hypertens; 2017; 39(4):325-329. PubMed ID: 28513233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.
    Attalah Nee Rezkallah C; Thongkum A; Zhu C; Chen QM
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22484. PubMed ID: 32196851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of atorvastatin in suppressing MUC5AC gene expression in human airway epithelial cells.
    Lee EJ; Song KJ; Hwang HJ; Kim KS
    Int Forum Allergy Rhinol; 2016 Nov; 6(11):1159-1166. PubMed ID: 27310028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consumption of high-dose statins in patients older than 65 years in the Republic of Croatia in the period 2005 - 2015.
    Grgurević D; Grgurević J; Bačić Vrca V; Marušić S; Marinović I
    Int J Clin Pharmacol Ther; 2021 Feb; 59(2):127-137. PubMed ID: 33040840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine-1-phosphate modulates both lipolysis and leptin production in differentiated rat white adipocytes.
    Jun DJ; Lee JH; Choi BH; Koh TK; Ha DC; Jeong MW; Kim KT
    Endocrinology; 2006 Dec; 147(12):5835-44. PubMed ID: 16973728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K; Pineda G; Newton RS; Fernandez ML
    Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions.
    Migliozzi DR; Asal NJ
    Ann Pharmacother; 2020 Feb; 54(2):171-177. PubMed ID: 31441337
    [No Abstract]   [Full Text] [Related]  

  • 34. Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes.
    Isusi E; Aspichueta P; Liza M; Hernández ML; Díaz C; Hernández G; Martínez MJ; Ochoa B
    Atherosclerosis; 2000 Dec; 153(2):283-94. PubMed ID: 11164417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
    Tungsubutra W; Phongtuntakul B
    J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis--guidelines vs. reality.
    Bożentowicz-Wikarek M; Kocełak P; Smertka M; Olszanecka-Glinianowicz M; Chudek J
    Pharmacol Rep; 2012; 64(2):377-85. PubMed ID: 22661189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB.
    Lee DK; Park EJ; Kim EK; Jin J; Kim JS; Shin IJ; Kim BY; Lee H; Kim DE
    Cell Physiol Biochem; 2012; 30(3):499-511. PubMed ID: 22814256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.
    Clarke AT; Johnson PC; Hall GC; Ford I; Mills PR
    PLoS One; 2016; 11(3):e0151587. PubMed ID: 26983033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes.
    Ganesan S; Ito MK
    Metab Syndr Relat Disord; 2013 Aug; 11(4):251-5. PubMed ID: 23496027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.